ArticleScientific reports2026
Tanycytic G6PT silencing prevents obesity induced by early postnatal overnutrition.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Tanycytes are ependymal glial cells that express the glucose-6-phosphate transporter (G6PT), which facilitates the incorporation of phosphorylated glucose from the cytosol into the reticular lumen. Herein, we show the antiobesogenic effects of G6PT-expressing tanycytes in a murine model of early postnatal overnutrition. Obesity in adult mice was induced by reducing litter size (SL mice) during the lactation period, a method that promotes excessive early nutrient intake. G6PT levels in tanycytes were analyzed using confocal-spectral microscopy. Tanycyte-specific G6pt silencing was carried out through the intracerebroventricular administration of AAV1-shG6pt-mCherry. Four weeks posttransduction, body weight, white adipose tissue weight, glucose metabolism and food intake were evaluated. We observed that SL mice exhibited reduced G6PT expression in tanycytes compared to mice with a normal phenotype. Remarkably, tanycyte-specific G6pt silencing in SL mice led to a significant reduction in body weight, accompanied by decreased adiposity. Furthermore, this intervention lowered blood glucose levels—restoring normoglycemia—and diminished food intake in response to fasting. These findings suggest that G6PT-expressing tanycytes may contribute to protective role against metabolic dysregulation. Targeting G6PT in tanycytes could help support the management and control of metabolic diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.